LA JOLLA, Calif., September 2, 2025 – Enlaza Therapeutics, the first covalent biologics platform company, today announced a multi-target drug discovery collaboration with Vertex Pharmaceuticals (Nasdaq: VRTX) to utilize Enlaza’s...
Art Pappas will be a panelist at the Small and Emerging Private Equity Manager Conference, organized by Credit Suisse's Customized Fund Investment Group, in Houston.
News | 04. 19. 2007
